Transgenic mouse expressing a full-length hepatitis C virus cDNA

被引：24

作者：

Matsuda, J

Suzuki, M

Nozaki, C

Shinya, N

Tashiro, K

Mizuno, K

Uchinuno, Y

Yamamura, K

机构：

[1] Kikuchi Res Ctr, Chemo Sero Therapeut Res Inst, Good Lab Practice GLP Ctr, Dept Pathol, Kumamoto 86912, Japan

[2] Kumamoto Univ, Inst Mol Embryol & Genet, Dept Dev Genet, Kumamoto 862, Japan

来源：

JAPANESE JOURNAL OF CANCER RESEARCH | 1998年 / 89卷 / 02期

关键词：

hepatitis C virus; transgenic mouse; human serum amyloid P component (hSAP) promoter;

D O I：

10.1111/j.1349-7006.1998.tb00543.x

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Hepatitis C virus (HCV), a major causative agent of post transfusion non-A, non-B hepatitis (NANBH), can only infect humans and chimpanzees, We produced nine transgenic mouse lines carrying a full-length HCV cDNA with the human serum amyloid P component (hSAP) promoter that can direct liver-specific expression, In one of these lines HCV mRNA and HCV core protein were detected in the liver of the transgenic mouse, although the levels of expression were very low. In addition, HCV-related antibody was detected in the serum.

引用

页码：150 / 158

页数：9

共 50 条

[11]

EITHAN G, 1995, J INFECT DIS, V172, P25

[12] GENETIC-TRANSFORMATION OF MOUSE EMBRYOS BY MICRO-INJECTION OF PURIFIED DNA [J].

GORDON, JW ;

SCANGOS, GA ;

PLOTKIN, DJ ;

BARBOSA, JA ;

RUDDLE, FH .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1980, 77 (12) :7380-7384

[13] CHARACTERIZATION OF THE HEPATITIS-C VIRUS-ENCODED SERINE PROTEINASE - DETERMINATION OF PROTEINASE-DEPENDENT POLYPROTEIN CLEAVAGE SITES [J].

GRAKOUI, A ;

MCCOURT, DW ;

WYCHOWSKI, C ;

FEINSTONE, SM ;

RICE, CM .

JOURNAL OF VIROLOGY, 1993, 67 (05) :2832-2843

[14] EXPRESSION AND IDENTIFICATION OF HEPATITIS C VIRUS POLYPROTEIN CLEAVAGE PRODUCTS [J].

GRAKOUI, A ;

WYCHOWSKI, C ;

LIN, C ;

FEINSTONE, SM ;

RICE, CM .

JOURNAL OF VIROLOGY, 1993, 67 (03) :1385-1395

[15]

HAYASHI N, 1993, J HEPATOL S1, V17, P94

[16] SELECTIVE TRANSMISSION OF HEPATITIS-C VIRUS IN-VIVO AND IN-VITRO [J].

HIJIKATA, M ;

MIZUNO, K ;

RIKIHISA, T ;

SHIMIZU, YK ;

IWAMOTO, A ;

NAKAJIMA, N ;

YOSHIKURA, H .

ARCHIVES OF VIROLOGY, 1995, 140 (09) :1623-1628

[17] GENE-MAPPING OF THE PUTATIVE STRUCTURAL REGION OF THE HEPATITIS-C VIRUS GENOME BY INVITRO PROCESSING ANALYSIS [J].

HIJIKATA, M ;

KATO, N ;

OOTSUYAMA, Y ;

NAKAGAWA, M ;

SHIMOTOHNO, K .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (13) :5547-5551

[18] Characterization of the nuclear localization signal and subcellular distribution of hepatitis C virus nonstructural protein NS5A [J].

Ide, Y ;

Zhang, LW ;

Chen, M ;

Inchauspe, G ;

Bahl, C ;

Sasaguri, Y ;

Padmanabhan, R .

GENE, 1996, 182 (1-2) :203-211

[19] Analysis of the cell tropism of HCV by using in vitro HCV-infected human lymphocytes and hepatocytes [J].

Ikeda, M ;

Kato, N ;

Mizutani, T ;

Sugiyama, K ;

Tanaka, K ;

Shimotohno, K .

JOURNAL OF HEPATOLOGY, 1997, 27 (03) :445-454

[20] Replication of hepatitis C virus in cultured non-neoplastic human hepatocytes [J].

Kato, N ;

Ikeda, M ;

Mizutani, T ;

Sugiyama, K ;

Noguchi, M ;

Hirohashi, S ;

Shimotohno, K .

JAPANESE JOURNAL OF CANCER RESEARCH, 1996, 87 (08) :787-792

← 1 2 3 4 5 →